Related Experiment Videos
The search for predictive patterns in ovarian cancer: proteomics meets bioinformatics
1Division of Population Science, Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia, PA 19111, USA. mb_daly@fccc.edu
Cancer Cell
|June 28, 2002
Abstract:
Proteomic patterns in serum that discriminate between malignant and benign ovaries may provide a powerful tool for screening in high risk women.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
PRANA: A Deep Learning Method for Adapting Polygenic Risk Scores to Diverse Ethnic Groups.
medRxiv : the preprint server for health sciences·2026
Steroids, stress, and body mass index interact to accelerate female pubertal development.
The Journal of clinical endocrinology and metabolism·2026
Personalized Decision-Making in Risk-Reducing Surgery of the Ovaries.
JAMA network open·2026
NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate, Version 2.2026.
Journal of the National Comprehensive Cancer Network : JNCCN·2026
Latent tumor killers awakened.
Cancer cell·2026
GLP-1RAs Use and Postoperative Outcomes in T2DM Patients Undergoing Radical Nephrectomy.
Clinical genitourinary cancer·2026
Timing of cholecystectomy after acute biliary pancreatitis: Impact of disease severity and biological sex.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2026
Association between pembrolizumab-based therapy exposure and survival outcomes in metastatic or recurrent uterine carcinosarcoma: a multi-center real-world study.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
Treatment and outcome of elderly patients with presumed early ovarian cancer in Germany: real-world observations from the quality-assurance program of the AGO Study Group.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026